Bardy Diagnostics
Latest round
- Series B
Last raised
- Apr 2019
Total raised
- $36M
Investors
- 9
About Bardy Diagnostics
Founded in 2013 in Seattle, US, Bardy Diagnostics develops specialized cardiac monitoring devices. The company has undergone a strategic shift leading to its acquisition by Hill-Rom Services Inc. in January 2021 for USD 375 mn.Bardy Diagnostics specializes in advanced cardiac monitoring solutions, particularly with its flagship product, the Carnation Ambulatory Monitor (CAM). Launched in 2013, the CAM is a lightweight ECG patch monitor designed for high-quality atrial signal capture, facilitating accurate arrhythmia diagnoses.Bardy Diagnostics generates revenue primarily through the sales of its CAM and associated services, including the BDxCONNECT patient management portal. The company uses a business-to-business model, engaging healthcare providers in subscription agreements for monitoring devices and comprehensive reporting services.The recent acquisition by Hill-Rom Services Inc. will enable Bardy Diagnostics to further develop its cardiac monitoring solutions and expand into new markets. The company is focused on increasing its market presence in North America and exploring opportunities in international markets through 2023.
Who invested in Bardy Diagnostics
9 investors across 1 round
See all investors in Bardy Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Apr 11, 2019
Amount
$36M
Investors
Questions about Bardy Diagnostics
Who invested in Bardy Diagnostics?
Bardy Diagnostics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bardy Diagnostics raised?
Bardy Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Bardy Diagnostics last raise money?
Bardy Diagnostics's most recent round on record is a Series B, in Apr 2019.
What does Bardy Diagnostics do?
Founded in 2013 in Seattle, US, Bardy Diagnostics develops specialized cardiac monitoring devices.
Where is Bardy Diagnostics headquartered?
Bardy Diagnostics is headquartered in Seattle, US.
Which VCs invest in companies like Bardy Diagnostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Bardy Diagnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Bardy Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.